{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Puromycin",
  "nciThesaurus": {
    "casRegistry": "53-79-2",
    "chebiId": "CHEBI:17939",
    "chemicalFormula": "C22H29N7O5",
    "definition": "An aminoglycoside antibiotic isolated from the bacterium Streptomyces alboniger.  Acting as an analog of the 3' terminal end of aminoacyl-tRNA, puromycin incorporates itself into a growing polypeptide chain and causes its premature termination, thereby inhibiting protein synthesis.  This agent has antimicrobial, antitrypanosomal, and antineoplastic properties; it is used as an antibiotic in cell culture.",
    "fdaUniiCode": "4A6ZS6Q2CL",
    "identifier": "C787",
    "preferredName": "Puromycin",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C259",
      "C784"
    ],
    "synonyms": [
      "Adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, (S)-",
      "Adenosine, 3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyl-, L-",
      "CL 16536",
      "L-3'-(alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine",
      "P-638",
      "PUROMYCIN",
      "Puromicina",
      "Puromycin",
      "Puromycine",
      "Puromycinum",
      "Stillomycin",
      "Stylomycin"
    ]
  }
}